VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Saturday, January 3, 2026
Stock Comparison
AstraZeneca PLC vs Zimmer Biomet Holdings, Inc.
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
AstraZeneca PLC
AZN · London Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into AstraZeneca PLC's moat claims, evidence, and risks.
View AZN analysisZimmer Biomet Holdings, Inc.
ZBH · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Zimmer Biomet Holdings, Inc.'s moat claims, evidence, and risks.
View ZBH analysisComparison highlights
- Moat score gap: Zimmer Biomet Holdings, Inc. leads (72 / 100 vs 71 / 100 for AstraZeneca PLC).
- Segment focus: AstraZeneca PLC has 6 segments (41% in Oncology); Zimmer Biomet Holdings, Inc. has 4 segments (41.3% in Knees).
- Primary market structure: Oligopoly vs Oligopoly. Pricing power: Strong vs Moderate.
- Moat breadth: AstraZeneca PLC has 4 moat types across 3 domains; Zimmer Biomet Holdings, Inc. has 7 across 5.
Primary market context
AstraZeneca PLC
Oncology
Innovator oncology therapeutics (branded prescription medicines)
Global
Hospitals, oncology clinics, payers
Innovator biopharmaceutical company
41%
Zimmer Biomet Holdings, Inc.
Knees
Knee reconstruction implants (primary, partial, revision) plus associated instruments and orthopedic robotics/navigation
Global
Hospitals and ambulatory surgery centers
OEM manufacturer
41.3%
Side-by-side metrics
Moat coverage
Shared moat types
AstraZeneca PLC strengths
Zimmer Biomet Holdings, Inc. strengths
Segment mix
AstraZeneca PLC segments
Full profile >Oncology
Oligopoly
Cardiovascular, Renal and Metabolism (CVRM)
Competitive
Respiratory & Immunology (R&I)
Oligopoly
Vaccines & Immune Therapies (V&I)
Oligopoly
Rare Disease
Oligopoly
Other Medicines
Competitive
Zimmer Biomet Holdings, Inc. segments
Full profile >Knees
Oligopoly
Hips
Oligopoly
S.E.T. (Sports Medicine, Extremities, Trauma, CMFT)
Competitive
Technology & Data, Bone Cement and Surgical
Oligopoly
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.